- Home
- GPK vs RYTM Comparison
GPK vs RYTM Comparison
Compare GPK & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPK
- RYTM
- Stock Information
- Founded
- GPK 2007
- RYTM 2008
- Country
- GPK United States
- RYTM United States
- Employees
- GPK N/A
- RYTM N/A
- Industry
- GPK Containers/Packaging
- RYTM Biotechnology: Pharmaceutical Preparations
- Sector
- GPK Consumer Discretionary
- RYTM Health Care
- Exchange
- GPK Nasdaq
- RYTM Nasdaq
- Market Cap
- GPK 6.1B
- RYTM 6.4B
- IPO Year
- GPK 1992
- RYTM 2017
- Fundamental
- Price
- GPK $17.15
- RYTM $110.20
- Analyst Decision
- GPK Hold
- RYTM Strong Buy
- Analyst Count
- GPK 8
- RYTM 13
- Target Price
- GPK $23.14
- RYTM $110.38
- AVG Volume (30 Days)
- GPK 3.3M
- RYTM 589.3K
- Earning Date
- GPK 11-04-2025
- RYTM 11-04-2025
- Dividend Yield
- GPK 2.56%
- RYTM N/A
- EPS Growth
- GPK N/A
- RYTM N/A
- EPS
- GPK 1.77
- RYTM N/A
- Revenue
- GPK $8,635,000,000.00
- RYTM $156,287,000.00
- Revenue This Year
- GPK N/A
- RYTM $46.14
- Revenue Next Year
- GPK $1.69
- RYTM $63.37
- P/E Ratio
- GPK $9.71
- RYTM N/A
- Revenue Growth
- GPK N/A
- RYTM 53.55
- 52 Week Low
- GPK $16.95
- RYTM $45.91
- 52 Week High
- GPK $30.70
- RYTM $113.91
- Technical
- Relative Strength Index (RSI)
- GPK 18.48
- RYTM 69.35
- Support Level
- GPK $16.95
- RYTM $97.97
- Resistance Level
- GPK $19.38
- RYTM $113.91
- Average True Range (ATR)
- GPK 0.39
- RYTM 3.77
- MACD
- GPK -0.11
- RYTM 1.20
- Stochastic Oscillator
- GPK 7.23
- RYTM 79.43
About GPK Graphic Packaging Holding Company
Graphic Packaging Holding Co is a holding company that manufactures and sells a variety of paper-based consumer packaging products through its subsidiaries. The company's reportable segments are; Paperboard Manufacturing, Americas Paperboard Packaging, and Europe Paperboard Packaging. The majority of the revenue is generated from its Americas Paperboard Packaging segment which includes paperboard packaging sold predominantly to consumer packaged goods (CPG) companies and cups, lids and food containers sold to foodservice companies and quick-service restaurants (QSR) serving the food, beverage, and consumer product markets in the Americas. Geographically, the company generates revenue from the Americas, Europe and Asia Pacific regions.
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.